Program subject to change. Please check back for updates.

Wednesday, October 25, 2017

Julie Khani, president of the American Clinical Laboratory Association, will lead what promises to be a lively discussion. Engage with Industry Leaders in a Panel Discussion of the Latest Regulatory and Health care reform issues and their Implications for the Diagnostics Industry. Among the panelists will be Vince Stine, Ph.D, Director of Government Affairs for American Association for Clinical Chemistry; and Julie Scott Allen, Washington Representative, The District Policy Group, National Independent Laboratory Association.
Speaker: Steve Shumpert, CEO of Sonic Healthcare USA

The lab industry is on the verge of a “golden age” of innovation and technological advancement that is literally unparalleled in history. From the emergence artificial intelligence and automation of high-volume testing, to rapid advances in molecular testing, the lab industry is transforming itself to deliver a new level of highly-advanced, highly-personalized, and highly-integrated diagnostic services. Join us to take a close look at where we are now, and where we are going, and what it means to your lab! In this special keynote presentation, Steve Shumpert, CEO of Sonic Healthcare USA, gives unique insight into the challenges facing Sonic, and the industry as a whole, and how Sonic is preparing now for new growth and profit opportunities open to diagnostic labs.

Thursday, October 26, 2017

Speaker: Keith Laughman, CEO of Viewics, Inc.

As we make the transition from volume to value, the laboratory has an opportunity to redefine how it’s measured and valued. Keith Laughman, CEO of Viewics, will be sharing objective and evidence-based strategies for how the practice of laboratory medicine can reposition the health system in value based care.

Healthcare reform is coming. But what form will it take? How will reform impact the diagnostic lab industry? If the new administration manages to pass healthcare reform before the end of 2017, will lab owners and managers face even greater uncertainty as new wave of rules, regulations and guidelines are put into place to implement and enforce the new legislation? This “critical-attend” round table session will take a Bipartisan look at the current political climate, the conflicting interests and goals of the many healthcare stakeholders, the various shapes reform can take, and most importantly, the direct impact of reform upon your labs policies, practices, growth opportunities, and competitive strategies.
Moderator: Shally Madan, Co-Founder and CCO, Luminate Health; Sam Terese, President and Chief Executive Officer at PCL Alverno / Alverno Clinical Laboratories
Presenters: Joyce Gresko, attorney in Alston & Bird’s Washington, D.C., office, where she is a member of the Health Care and Legislative & Public Policy Teams; Kyle Fetter, VP & General Manager of Diagnostic Services, XIFIN, Inc.

This panel discussion will address the regulatory and compliance issues that regulatory and oversight entities are focusing on in the laboratory and pathology context including the latest developments concerning Laboratory Developed Tests, Direct to Consumer diagnostics, genetic testing and laboratory quality and patient safety

Afternoon Breakout Sessions 

Redesigned breakout sessions focus on maximizing your laboratory’s or pathology practice’s efficiency, profitability, growth and innovation to benefit your bottom line

(1:45 p.m. – 2:45 p.m.)
Billing, Coding and Payment Update for 2018

In this session Diana Voorhees, nationally-recognized coding and billing expert, will provide a close look at how to comply with the perennial lab challenges including documenting medical necessitytest order documentation, unbundling for ADLTwaiving co-pays and deductiblesup-codingfalse claims liabilitykickbacks, and more.  Plus you’ll explore how the rules are evolving and being applied to novel billing, coding and reimbursement issues, and review critical billing and coding changes upcoming for 2018.

(3:15 p.m. – 4:15 p.m.)
Compliance: Key Trends and Potential Vulnerabilities

Presenters: Robert Mazer, Shareholder with Baker Donelson; Kristin Carter, Shareholder with Baker Donelson

This presentation will explore compliance issues and trends for clinical laboratories, including current enforcement initiatives. This presentation will address, among other things, medical necessity issues, CLIA proficiency testing issues, private payor actions, arrangements that exclude federal beneficiaries, direct access testing and additional compliance topics.

(4:30 p.m. – 5:30 p.m.)
Laboratory 2.0 – How Tri-Core’ Innovation Strategy Created a New Revenue Strategy

Speaker: Rick VanNess, Director, Product Development – TriCore Reference Laboratories

During a time of uncertain revenue streams, TriCore Reference Laboratories is attempting to create a new revenue stream through generating actionable information from laboratory data to produce better patient outcomes. Utilizing Rhodes Group’s evolutionary platform, TriCore provided valuable insights to a large New Mexico payer regarding the prenatal status of several hundred members. With the data serving as a catalyst to better care co-ordination processes, a significant number of care gaps were closed, NICU LoS was lower, and incentivized quality measures were increased for the payer. After calculating the project’s value and extrapolating the value to an annual projection, TriCore has created a business model to generate new revenue.

(1:45 p.m. – 2:45 p.m.)
Sales and Marketing Strategies for Outreach Success

Presenter: Joseph Song, Chief Executive Officer, Associated Pathology Medical Group

From basic to complex ideas, a complete overview of strategies for lab outreach. For beginners and the experienced alike, a comprehensive discussion of today’s obstacles in sales and marketing, strategies for each specialties and common questions answered in today’s difficult landscape. Will also discuss what makes a successful sales representative and how to keep them happy.

(3:15 p.m. – 4:15 p.m.)
Using Laboratory Analytics to Manage Over and Underutilization of Testing for Better Patient Care and Improved Financial Performance

Presenter: Thomas Joseph, President and CEO at Visiun

Managing test utilization in order to reduce unnecessary testing is one of the greatest opportunities for laboratories to improve financial performance while enhancing patient care. This session will provide an overview of the approaches health systems are using to manage both overutilization and underutilization, and how analytics can drive improved utilization practices. Surveys of physician practice patterns will be discussed along with key benchmarks and assessments of the scale of opportunities across the industry.

Purpose of Presentation:
To provide an overview of changes driving review of test utilization practices, the variety of approaches health systems have to control over and underutilization of testing, and how analytics can drive improved utilization practices.
Key Topics:

  • Consequences of unnecessary testing for patient care (Ex: Iatrogenic anemia, time spent on insignificant results, missed and delayed diagnoses, incorrect diagnoses, increased length of stays)
  • Common categories of unnecessary testing (Ex: ordering an FT4 when the TSH is normal, redundant testing such as troponin and CKMB’s ordered together, and excessive frequency of repeat testing.)
  • How analytics can identify key opportunities for improved utilization practices and ongoing audits of physician practice patterns (Ex: Limiting esotetric tests, posting guidelines, and minimizing bundles of tests, and test auditing)
  • An analysis of industry data including variations in physician practice patterns
  • The scale of opportunities (percent of test volume and reduction in expense)

(4:30 p.m. – 5:30 p.m.)
How Leadership Drives Innovation – Maintaining Focus, Avoiding Distractions

Presenter: Lee Hubert, MBA, SPHR – SCP, Principal Consultant, Voltage Leadership Consulting

The laboratory industry and the people who lead it, are often faced with an overwhelming amount of data input resulting in “sensory overload.” Prioritizing operational concerns while dealing with distractions can be a daunting task especially given the pace at which the laboratory business often runs at. Please join us for a highly iterative session about practical tips and tools laboratory professionals can use to help consistently show up at their best. This session helps laboratory leaders learn how to minimize distractions, design their time and maintain focus on what is most important.

Learning Objectives:

  • Learn what our “best” days and ‘most challenging” days have in common
  • Learn to overcome the “tyranny of the present”
  • Review practical guidance for handling interruptions
  • Receive tips for removing “drama” for laboratory environments
  • Learn to find more time to focus on things that matter most
(1:45 p.m. – 2:45 p.m.)
Case Study: Growing a Specialty Diagnostic Company: Raising Capital, Gaining Reimbursement Coverage and Negotiating Out of Network and Growth Strategies

Speaker: Derek Maetzold, Founder, President and CEO of Castle Biosciences

(3:15 p.m. – 4:15 p.m.)
Case Study: How One Lab’s Growth Strategies Exceeded Sales Goals by 107% while Retaining 95% of Existing Business

Presenters: Nate Koenig,Chief Marketing Officer, Incyte Diagnostics; Ryan Berk, Business Analyst, Incyte Diagnostics

(4:30 p.m. – 5:30 p.m.)
Case Study: How One Company is Creating New Market Streams for Laboratories and Making Use of Overlooked Assets

(1:45 p.m. – 2:45 p.m.)
Setting the Stage for Financial Improvement in the Lab: Doing More With Less and Driving Results

Presenter: Jeffrey H. Myers, CPA, Vice President of Consulting for Accumen Inc.

Join this engaging session to gain valuable insight on how to position the clinical laboratory for sustainability and growth with increased legislative demands including PAMA and the corresponding reimbursement cuts on the business. Discover industry best practices that drive performance improvement which may be complex, but if properly executed, a forward looking laboratory strategy can improve expense performance and provide revenue growth. Understanding industry specific benchmarks affords the organization the ability to realize margin improvement through optimizing labor, non-labor, and other core costs of the laboratory while maintaining the highest quality for patient care.

(3:15 p.m. – 4:15 p.m.)
Out-of-Network 101: Learn How to Maximize Reimbursements

Speakers: John Bartos, CEO, Collect Rx; Richa Singh, EVP, Collect Rx

As providers survey the landscape today, there aren’t many opportunities to improve reimbursements rates. Your in-network contracts are hard to change, and Medicare and Medicaid reimbursements are what they are. But out-of-network represents a last, great opportunity for many providers to bring more dollars in the door to improve the bottom-line.

Learning Objectives:

  • Learn the basics of out-of-network
  • Discover how out-of-network can be leveraged to increase your reimbursements
  • Uncover the issues that arise with respect to third party rental network agreements (and Silent PPOs)
  • Find more time to focus on patient care

(4:30 p.m. – 5:30 p.m.)

Friday, October 27, 2017

The Patient-Centric Laboratory: A Renewed Focus
Speaker: Jane Hermansen MBA, MT(ASCP), Manager, Network and Outreach Development, Mayo Medical Laboratories, Rochester

Laboratory testing is absolutely necessary for patient care, and the role of high-value diagnostics continues to increase in importance across the continuum of care. High quality, cost-effective and appropriately-utilized laboratory tests are essential in achieving healthcare’s Triple Aim.

Today, the physician-centric model of “Doctor Knows Best” is no longer the only consideration. Have we ever asked the patient, “What will an abnormal result mean to you?” With the patient at the center, healthcare delivery systems must leave the status quo behind and develop processes that are intentionally focused on what is important to the patient. This focus will drive improvements in patient transactions, access and efficiency while managing costs; and when managed properly will create increased loyalty and improved outcomes.

Learning Objectives:

  • Describe the difference between physician-centric and patient-centric laboratory testing
  • Identify the role that the laboratory has in achieving healthcare’s Triple Aim
  • Develop a plan to upgrade your laboratory to providing patient-centric services
The Future of Healthcare AI in the Lab
Speaker: Jason Bhan, Co-Founder and Chief Medical Officer at Prognos

Despite having significant amounts of data playing a vital role in clinical decision making, most laboratories have not yet invested in a strategic data strategy or even leveraged their individual data assets. However, the rest of the healthcare industry has made great strides in exploring the potential and harnessing the power of big data, advanced analytics, and Artificial Intelligence (AI) to grow business and improve patient outcomes.

This session, hosted by Prognos Cofounder & CEO, Jason Bhan, MD, will explain why healthcare AI should be welcomed into labs, as several leading laboratories have begun to do by partnering with AI experts to leverage and grow their businesses. Join us to learn how lab data insights can benefit physicians, patients, therapy developers, and health plans, and what that can mean for a lab’s commercial success.

Speaker: David Nichols, MBA, President of The Nichols Management Group (NMG)

What are the trends determining your lab’s success today and in the future? This presentation will cover factors in the clinical and anatomic laboratory market, including size, growth rate, regulatory and reimbursement trends and niche trends. For hospital laboratories, you will hear about overall trends, and strategic options including outreach growth, sale of outreach, and inpatient management with the sale of outreach. A review of major hospital deals with nationals in the last five years will include the structure of deals, and considerations for hospitals to keep in mind when evaluating options will also be covered. New technologies and critical factors for success will round out the picture of future trends and impacts.